Published on in Vol 27 (2025)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/68291, first published
.

Journals
- Nwokedi V, Odedele M, Yusuff T, Anderson I, Akanbi O, Agu C, Omoike A. Developing and Validating Predictive Models for Adverse Drug Reactions using Electronic Health Records (EHRs): A Narrative Review. Epidemiology and Health Data Insights 2025;1(6):ehdi019 View
- Chinnadurai R, Madabhushi A. Opportunities with artificial intelligence in assessing the potency of mesenchymal stromal cells. Stem Cells 2026;44(1) View
- Jing H, Jie D, Zhong W, Xiao M, Qingxuan Z, Sha L, Shuai Z, Yunyan X, Mingxiao L, Yahui L. Active monitoring vs. spontaneous reporting of antineoplastic drug–related adverse drug reactions: evidence from the Chinese hospital pharmacovigilance system. Frontiers in Health Services 2026;5 View
